Cargando…
Disialogangliosides GD2 and GD3 are involved in the attachment of human melanoma and neuroblastoma cells to extracellular matrix proteins
Human melanoma cells express relatively large amounts of the disialogangliosides GD3 and GD2 on their surface whereas neuroblastoma cells express GD2 as a major ganglioside. Monoclonal antibodies (Mabs) directed specifically to the carbohydrate moiety of GD3 and GD2 inhibit melanoma and neuroblastom...
Formato: | Texto |
---|---|
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
1986
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2114134/ https://www.ncbi.nlm.nih.gov/pubmed/3005335 |
Ejemplares similares
-
Disialoganglioside GD2 distributes preferentially into substrate- associated microprocesses on human melanoma cells during their attachment to fibronectin
Publicado: (1986) -
Cross-presentation of Disialoganglioside GD3 to Natural Killer T Cells
por: Wu, Dianna Y., et al.
Publicado: (2003) -
Variable Expression of the Disialoganglioside GD2 in Breast Cancer Molecular Subtypes
por: Erber, Ramona, et al.
Publicado: (2021) -
Identification and Tumour-Binding Properties of a Peptide with High Affinity to the Disialoganglioside GD2
por: Müller, Jan, et al.
Publicado: (2016) -
Disialoganglioside GD2 Expression in Solid Tumors and Role as a Target for Cancer Therapy
por: Nazha, Bassel, et al.
Publicado: (2020)